Seattle Genetics Reports Fourth Quarter and Full Year 2019 Financial Results
Seagen Inc. (SGEN)
Last seagen inc. earnings: 4/30 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.seattlegenetics.com
Company Research
Source: Business Wire
-ADCETRIS® (Brentuximab Vedotin) Net Sales in U.S. and Canada of $627.7 Million in 2019, Including $166.2 Million in the Fourth Quarter--PADCEV™ (Enfortumab Vedotin-ejfv) Granted Accelerated Approval by FDA for Patients with Locally Advanced or Metastatic Urothelial Cancer Following Platinum-based Chemotherapy and a PD-1 or PD-L1 Inhibitor; U.S. Commercial Launch Underway--Tucatinib Applications for Approval Submitted to the FDA and EMA for Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer--Conference Call Today at 4:30 p.m. ET- BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the fourth quarter and year ended December 31, 2019. The Company also highlighted ADCETRIS (brentuximab vedotin) and PADCEV (enfortumab vedotin-ejfv) commercial, regulatory and clinical development accomplishments and progress with its clinical programs for cancer, including tucatinib.“At the end of 2019, we became a multi-produc
Show less
Read more
Impact Snapshot
Event Time:
SGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGEN alerts
High impacting Seagen Inc. news events
Weekly update
A roundup of the hottest topics